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ABSTRACT
￿
Past studies of norepinephrine-stimulated protein phosphorylation in intact C-6 glioma
cells had identified a 58,000 molecular weight, 5.7 isoelectric point protein (58K-5.7) as a cyclic AMP-
dependent phosphoprotein and had shown that 58K-5.7 was one of the most abundant proteins of
the nuclear fraction . Initial experiments of present studies showed that the 58K-5.7 protein remained
with the nuclear ghost, or matrix structure, after removal of chromatin. Based on the size, acidity,
abundance, nonsolubilization by nonionic detergent and salt, and solubilization by urea, the hypoth-
esis was advanced that the 58K-5.7 protein was the vimentin-type intermediate filament protein. The
hypothesis was tested by two types of immunochemical experiments. Antisera against hamster
vimentin reacted selectively with only the 58K-5.7 protein in polyacrylamide gels of urea-solubilized
cellular residues (i .e., nonionic detergent and 0.6 M salt-insoluble material) as determined by
immunoautoradiography. Antisera against the pure 58K-5.7 protein of C-6 cells bound selectively to
a fibrous array of cellular material typical of vimentin filaments as determined by indirect immuno-
fluorescence. It is concluded that the 58K-5.7 protein is vimentin .
A number of hormones that interact with receptors on the cell
surface have been shown to exert their effects on the cell by
raising the intracellular concentration ofthe second messenger,
cyclic AMP. These hormones include norepinephrine (acting
at iQ-adrenergic receptors), glucagon, ACTH, prostaglandins,
and others (32). The evidence is mounting that cyclic AMP acts
in higher eukaryotes by stimulation of specific protein phos-
phorylations catalyzed by cyclic AMP-dependent protein ki-
nases (25). When rat C-6 glioma cells are treated with norepi-
nephrine, synthesis of several enzymes is induced (3, 14, 24,
36), the cells change shape (28), nerve growth factor is synthe-
sized and released (37), and glycogenolysis is activated (8). We
have investigated the changes in protein phosphorylation in
intact C-6 cells after norepinephrine treatment and found that
phosphate content in eight polypeptides reproducibly and sig-
nificantly increases within 5 min (17, 34). One of these poly-
peptides, previously designated 58K-5 .7 for its molecular
weight and isoelectric point, is a major protein in the cell and
copurifies with nuclei in subcellular fractionation experiments
(17). We report here the identification of the 58K-5.7 protein
as the vimentin-type intermediate filament protein of the cy-
toskeleton of these cells.
MATERIALS AND METHODS
Cell Culture
C-6 glioma cells were grown to postconfluent density on the surface of glass
roller bottles or glass cover slips in Ham's F-10 medium as described previously
(8, 9). Some ofthe later rollerbottle cultures used for 58K-5.7 protein purification
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were grown in 10% calf serum in place of fetal calf serum with no apparent
change in cellular content of the 58K-5.7 protein.
Selective Extraction and Purification of the 58K-
5.7 Protein
Surface cultures in roller bottles (2,660 cm' of surface area for two bottles),
containing -100 mg of cellular protein, were washed three times at 0°Cwith 200
ml/bottle ofHam's F-10 medium and once with 10 mM HEPES, 2 mM MgCh,
pH 7.4 (HEPES-Mg). Cells were scraped into 100 ml/bottle HEPES-Mg, the
bottle was rinsed with 100 ml HEPES-Mg, and pooled material was centrifuged
as IO,000g for 10 min at 0°C. Cellular pellets were dispersed by homogenization
in 70 ml HEPES-Mg containing 0.5% Nonidet P-40 (NP-40). Thehomogenate
was stored for 10 min on ice and centrifuged for 10 min at 20,000g (standard
centrifugation conditions for the remainder of the procedure). The resulting
pellets were resuspended at room temperature in 35 ml of HEPES-Mg-NP-40
containing 0.6 MKCland the protease inhibitors, 0.1 mM phenylmethylsulfon-
ylfluoride and I mM sodium tetrathionate. The pellets were immediately homog-
enized vigorously in a Teflon glass homogenizer and allowed to stand at room
temperature for 10 min. This homogenate was centrifuged at room temperature
and the KCt extraction was repeated. The pellet was resuspended at room
temperature in HEPES-Mg containing 4 M urea at pH 8.0 and dispersed by
vigorous homogenization . This suspension was allowed to stand for 30 minand
centrifuged. Approximately one-half of the 58K-5.7 protein was released by the
4 M urea treatment. The4 M urea extract was dialyzed to remove excess urea
and lyophilized. That the band present in 4Murea extract and in the final pellet
were the same polypeptide was confirmed by peptide mapping according to
Bordier and Crettol-Jarvinen (6) (data not shown).
The 58K-5.7 protein was purified from the 4 M urea extract and from the
finalpellet by twocyclesofSDS-gradient slabgelelectrophoresis. The Lyophilized
4 M urea extract was taken up in 0.5 ml of 4 M urea and prepared for
electrophoresis (see Electrophoresis Conditions). Thefinal pellet was taken up in
1 ml of water and dispersed by sonication (Branson model 185D sonifier,
microtip, 40 s, setting 4 [Branson Sonic Power Co., Danbury, Conn.)) which
803reduced the viscosity of the sample. The sonicate was made up to the same final
concentration ofglycerol, SDS, mercaptoethanol and Tris as the 4 Murea extract.
The solubilized samples were then electrophoresed separately. The gels were
stained with 0.2% Coomassie Brilliant Blue Rin 50 mM Tris buffer, pH 6.8, for
15 min, destained for a few minutes, and the 58K band was cut from each gel.
The partially purified material was stored overnight at 0°C, pooled, homogenized
in 1 ml of sample buffer, and applied to the top of a second gel and electropho-
resed, stained, and cut from the gel as before. The58K-5.7 protein was electro-
phoretically elutedfromthe second gel using an ISCO model 1750 electrophoretic
concentrator (Instrumentation Specialties Co., Lincoln, Nebr.). Thestrip ofgel
was chopped and placed in a Nylon mesh basket above the small cup of the
apparatus. The electrode buffer was 40 mM Tris acetate, 0.2% SDS, 2 mM
EDTA, pH 8.0 and the cup buffer was 4 mM Tris acetate, 0.2% SDS, 0.2 mM
EDTA, pH 8.0. Elution was performed at 10 mA during two 90-min periods.
Electrophoresis Conditions
Two-dimensional polyacrylamide gel electrophoresis was conducted by elec-
trofocusing in the first dimension and discontinuous SDS gel electrophoresis in
the second dimension as described previously (17). A 5-16% log-linear gradient
gel was used for the second-dimensional gel. One-dimensional electrophoresis
was conductedusing essentially the same gradient slab gelas for two-dimensional
separations. Samples for one-dimensional separations were made up in the
sample buffer ofLaemmli (22), by mixing 2:1 with a three-times concentrate of
the sample buffer.
Immunoautoradiography
The experimental approach was essentially that of Burridge (10) as used for
the intermediate filament protein by Hynes and Destree (18). Briefly, the 58K-
5.7 protein was electrophoresed in the gradient SDS gel system used for protein
purification and slices ofgel were cut along the molecular weight axis. One slice
was fixed, stained with 0.2% Coomassie, and destained. The other slices were
fixed but not stained and these gels were equilibrated with buffer A (10). The
unstained gel slices were then exposed overnight to antivimentin serum diluted
1 :10, washed for 36 h, and exposed overnight to "I-goat anti-rabbit serum
(GAR) and again washed. Theresulting gel slices were dried against filter paper
and subjected to autoradiography using Kodak XB-5 film and a KodakX-omatic
fluorescence enhancement screen. The '.
"I-GAR was prepared using alactoper-
oxidase-glucose oxidase iodination kit with GAR bound to 1 ml of Sepharose-
rabbit IgG gel. The Sepharose-IgG was prepared by reacting 5 mg of rabbit IgG
fraction with 1 ml of cyanogen bromide-activated Sepharose 4B. The resulting
"'I-GAR was essentially pure IgG as indicated by polyacrylamide gel electro-
phoresis.
Immunization of Rabbits
Rabbits were immunized with -200 pg of pure 58K-5.7 protein in polyacryl-
amide gel. The gel was emulsified in Freund's complete adjuvant and injected
subcutaneously . At monthly intervals thereafter, booster injections of 50-200 jig
of58K-5.7 were given either in gel or in phosphate-buffered saline, in each case
emulsified with Freund's complete adjuvant. Animals were bled 1 wk after each
booster injection. Control animals received injections of Freund's complete
adjuvant emulsified with either gel or phosphate-buffered saline as appropriate.
Immunofluorescence
An indirect immunofluorescence procedure was usedwhich employed the sera
resulting from the above immunization as the primary antibody and utilized
fluorescein-conjugated GAR-IgGas the indicator antibody. Fixation ofC-6 cells,
permeabilization, and incubations with antibodies were conducted essentially as
described by Hynes and Destree (l8), except that the C-6 cells were washed for
30 min at pH 9.5 after the reactions with the rabbit antibody to elute nonspecif-
ically bound protein (4). Cover-slip samples ofcells were mounted in50%glycerol
in phosphate-buffered saline and examined in a Zeiss Universal microscope
equipped for epifluorescence using FITC filters.
Materials
Rabbit antiserum against hamster NIL-8 cell vimentin-type intermediate
filament protein was a gift from Dr. Richard O. Hynes, Massachusetts Institute
of Technology. GAR-IgG and fluorescein-conjugated GAR-IgG fraction was
obtained from Cappel Laboratories, Cochranville, Pa. Cyanogen bromide acti-
vated Sepharose 4B was obtained from Pharmacia Fine Chemicals, Piscataway,
N. J. Thelactoperoxidase glucose oxidase iodination materials were obtained as
a kit from NewEngland Nuclear, Boston, Mass. S. aureus strain VA protease was
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obtained from Miles Laboratories, Inc., Elkhart, Ind. "Piwas obtained from ICN
Pharmaceuticals, Irvine, Calif Materials were obtained as described previously
for nuclear subfractionation (33), gel electrophoresis (17), and cell culture (9).
RESULTS
The first step toward establishing the identity of the 58K-5.7
protein was to subfractionate the nonionic detergent-treated
nuclear preparation. This was accomplished by micrococcal
nuclease treatment and stepwise salt extraction (33). The pro-
cedure generates a fraction of soluble nuclear proteins (SO),
four structurally different nucleosome subfractions (SS2, SS3,
SS4, and SS6), and a residue (P6). Samples from the intact
nuclei and the nuclear subfractions were coelectrophoresed
with whole cell extracts in two-dimensional polyacrylamide
gels (17, 29). The 32P-labeled 58K-5 .7 protein is present in the
nuclei as indicated by autoradiography (Fig. 1 B) and by
increased abundance of the spot in the stained gel (Fig. 1 A).
It is essentially absent from SO and SS2 autoradiograms (Fig.
1 D and F) and the relative intensity of the stained spot in
these subfractions is typical of whole cell extract alone. It was
also absent from SS3, SS4, and SS6 (not shown). The 58K
phosphoprotein was enriched in the P6 fraction (Fig. 1 G and
H) which includes the nuclear matrix or ghost structure, de-
pleted of chromatin, but with cytoskeletal elements stable to
the nuclear fractionation conditions still attached. For example,
vimentin-type intermediate filaments are known to resist both
the nonionic detergent and the 0.6 M NaCl extractions of
cultured cells (7, 39).
A number of reagents, including detergents, reducing agents,
chelating agents, and denaturants were tested as agents for
solubilizing the 58K-5.7 protein from the nuclear ghost. Of
these, SDS was effective but completely unselective, and most
of the other agents were completely ineffective. However, 4 M
urea solubilized one-half or more of the 58K-5 .7 protein (data
not shown). Urea is known to solubilize several intermediate
filament proteins including vimentin from the nonionic deter-
gent-treated cellular residues (39). From its abundance, size,
isoelectric point, subcellular distribution, and solubilization
characteristics, the working hypothesis was advanced that the
58K-5.7 protein was the vimentin-type intermediate filament
protein of the C-6 glioma cell (see Discussion).
The 58K-5.7 protein was purified to provide material for
further testing of its identity. Cultures were successively ex-
tracted with nonionic detergent and salt to solubilize most
extraneous cellular proteins. The residues from these extrac-
tions were solubilized with urea or SDS and purified by two
cycles of SDS-gradient slab gel electrophoresis. The product
was pure in that it gave rise to a single spot in a two-dimen-
sional gel at high load (Fig. 2A). That the pure protein was
unaltered during purification was substantiated by coelectro-
phoresis of the purified material with the 58K-5.7 protein of
C-6 cell whole cell extract (Fig. 2B and C).
The reactivity of the 58K-5.7 protein with antisera to the
vimentin-type intermediate filaments of cultured hamster NIL-
8 cells (18) was tested using the immunoautoradiographic
procedure of Burridge (10). Fig. 3 shows stained polyacryl-
amide gel strips and autoradiograms ofseparate slices from the
same gels that have been incubated with the rabbit antiserum
against vimentin and subsequently with 1251-GAR. Panels A-C
show the 4 M urea extract of the cells and panels D and E
show the final purification gel of a separate experiment. The
t25I-GAR second antibody showed some reactivity with the
low molecular weight proteins of the gel (A) but when antibodyFIGURE 1
￿
Salt fractionation of nuclease-digested nuclei to establish
nuclear location of the 58K-5 .7 protein . A roller bottle culture (230
cm' of surface) of C-6 glioma cells was washed with 100 ml of
Ham's F-10 medium followed by 100 ml Ham's F-10 containing
one-sixth the normal amount of phosphate (low phosphate Ham's
medium) containing 6 mCi (1 Ci = 3.7 x 10'o bequerels) 32 Pi for 4
h at 37 ° C . At the end of the incubation, the medium was aspirated
and the cells were scraped from the bottle surface into 10 ml of
Earle's balanced salt solution . They were collected by centrifugation
at 1,000 rpm at room temperature, loaded with glycerol and lysed
by hypotonic shock (19) in 1 mM Tris, 25 M KCI, 0.9 M M9Cl2 , 0,9
mM CaCl2 , 0.14 mM spermidine, pH 7 .6 (C buffer) . Nuclei were
collected by centrifugation at 3,000 rpm for 10 min at 4°C in a
Sorvall HB-4 rotor. They were washed once with C buffer containing
0.5% NP-40 and resuspended in 0 .5 ml of C buffer . After digestion
with 100 U of micrococcal nuclease for 5 min, the digested nuclei
were centrifuged as before and extracted stepwise with C buffer
containing 0.2, 0 .3, 0.4, and finally 0 .6 M NaCl (33) . Samples of the
whole nuclear digest (N), each of the solubilized subfractions (des-
ignated So , SS 2 , SSa, and SS6 with the subscript indicating the NaCl
concentration at which the fraction was solubilized) and the residue
remaining after all the nucleosomes had been eluted (P6) were
precipitated with 2 vol of ethanol at -20°C for 16 h and solubilized
(17) for gel electrophoresis .
Subfractions of "P-labeled C-6 nuclei were coelectrophoresed in
two dimensions with unlabeled whole cell extracts as described in
Materials and Methods . The gels were stained, dried, and autora-
diograms were prepared . The arrow indicates the known position of
the 58K-5 .7 protein . Stained gels : whole cell extract plus intact
nuclei (A), subfractions So (C), SS2 (E), and P6 (G) . Autoradiograms :
nuclei (8), So (D), SS2 (F), and P 6 (H) .
against vimentin had been present (B), only one additional
band was labeled . This antivimentin antibody-reactive band,
was the 58K-5.7 band . Binding of the rabbit antivimentin
FIGURE 2
￿
Purity of the 58K-5 .7 following selective extraction and
purification in polyacrylamide gels . The purified product was elec-
trophoresed in two-dimensional gels as described elsewhere (17)
either alone (panel A) or mixed with whole cell extract (C) . A
sample of whole cell extract alone at equivalent load is presented
in panel 8 . The arrow indicates the 58K-5.7 protein in panels 8 and
C .
serum to 58K-5.7 was also observed in the final purification
gel (D) where the 58K-5.7 protein band was pure. Therefore,
antifilament antibody reacted selectively with the 58K-5.7
protein . This result strongly supports the conclusion that the
58K-5.7 protein is vimentin .
A second type of immunochemical experiment consisted of
raising antibody to pure 58K-5.7 from C-6 cells and conducting
an indirect immunofluorescence evaluation ofits reaction with
fixed C-6 cells adherent to cover slips . Fluorescence micro-
graphs shown in Fig. 4 (A and B) indicate that the antiserum
to 58K-5 .7 reacted with a fibrous extranuclear network that
formed a "halo" or swirl around the nucleus and pervaded the
cytoplasm of the cell . Preimmune serum (Fig. 4 C) gave a more
general fluorescent reaction with only a slight reaction with
cytoskeletal fibers. Reaction of the cells to fluorescein-labeled
GAR alone produced only a low level of generalized fluores-
cence (Fig . 4 D) . The fibrous fluorescent pattern seen with the
antiserum to 58K-5.7 remained after a 2-h incubation of cells
at 0°C before fixation, indicating that the fibers were not cold
sensitive and therefore were probably not microtubules (Fig .
4E) . In experiments not shown, treatment of the cells with
cytocholasin B or colcemid caused the fluorescent structures to
condense into aggregated cablelike structures . Comparison of
the fluorescence pattern with that seen with conventional
phase-contrast microscopy indicated that the fluorescent struc-
tures were often identified with phase-dark elements of the
cytoplasm, often particularly easily identified near the margins
of the cell (Fig . 4 F, G, arrows) . This phase-dark material
RAPID COMMUNICATIONS
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805FIGURE 3 Cross-reaction of antiserum to hamster vimentin with
58K-5 .7 protein of rat C-6 cells . Strips of slab gels that resolved
either the 4 M urea-solubilized residues (A-C) or the "one cycle"
purified material (D, E) were cut and either stained with Coomassie
brilliant blue (C, E) or exposed to antisera as described in Materials
and Methods . A is an autoradiogram showing the reaction of '261-
GAR alone with proteins of the gel . B and D are autoradiograms
showing reactions of the antivimentin serum followed by exposure
to '261-GAR .
accounts for a significant fraction of the internal fibrous ma-
terial of the cells visible by phase-contrast microscopy. Com-
parison of visual fields using phase and fluorescence optics
indicated that most, if not all, cells contained the fluorescent
structures. It is concluded that the fibrous fluorescence pattern
was due to the 58K-5.7 protein and that the protein is a
constituent of a fibrous cytoskeletal network that has been
described for vimentin-type intermediate filaments (15, 16, 18,
40) .
DISCUSSION
Present work demonstrates that a 58,000-dalton, norepineph-
rine-dependent phosphoprotein (58K-5.7) ofintact C-6 glioma
cells is the vimentin-type intermediate filament protein of the
cytoskeleton of these cells . The evidence for this conclusion is
of three types . First, the two proteins share a number of
physical properties . Vimentin is a 54-58,000-dalton polypep-
tide (4, 15, 18, 39) as is 58K-5.7 and both proteins are acidic
(7, 17) . The 58K-5 .7 protein is one of the 10 or so most
abundant proteins in C-6 cells ; vimentin is also a highly
abundant protein in other cell types (7) . Vimentin resists
solubilization from cellular material by nonionic detergents (7)
and by 0.6M salt (4, 39) but is solubilized by urea or SDS (39) .
We showed previously that the C-6 58K-5.7 protein resisted
solubilization by nonionic detergents and remained associated
with the nuclear fraction after this treatment (17) . Present
experiments show that the protein is resistant to 0.6 M KC1
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extraction of the nuclear fraction (Fig. 1) but is partially
solubilized by urea at low ionic strength and completely solu-
bilized by SDS (Materials and Methods) . It was previously
established that the protein is distinct from tubulin (17) .
The second type of evidence that the two proteins are related
is that antiserum against vimentin of hamster cells cross-reacts
with the 58K-5 .7 protein . The vimentin antiboy reacted not
only with the 58K-5.7 protein in purified form but also selec-
tively reacted with the 58K-5 .7 protein in the gel that resolved
the 4M urea-solubilized material .
The third line of evidence that the 58K-5.7 protein was the
intermediate filament subunit came from indirect immunoflu-
orescence studies . Rabbits were immunized with pure 58K-5.7
from C-6 cells and the resulting antiserum was used to test for
localization of 58K-5.7 protein within C-6 cells . The fluores-
cence pattern was a halo of fibrous material surrounding the
nucleus and a fibrous network that spread throughout the
cytoplasm of the cell . The nuclei were essentially unstained.
This pattern of fluorescence was typical of that seen with the
vimentin-type intermediate filaments using similar techniques
in other cell types (15, 16, 18, 40) .
Hormone-dependent phosphorylation of vimentin has not
previously been observed in intact cells . That vimentin was
phosphorylated on a small fraction of its copies was described
for two cell types (12, 26) but modulation of phosphorus
content by cyclicAMP was not demonstrated . Our observation
of the norepinephrine-stimulated phosphorylation showed a
twofold increase in 'P content of vimentin following hormone
treatment (17). The change due to norepinephrine can be
increased to four to fivefold by the addition of actinomycin D
to the incubation fluid along with the "Pi ; actinomycin D
decreases the 32P incorporation into vimentin during the 32P
equilibration .'
A report of in vitro studies has appeared (27) that showed
phosphorylation of vimentin by two kinases that seemed to be
the CAMP-dependent protein kinases . However, interpretation
of the in vitro findings are difficult . The catalytic subunit of
cyclic AMP-dependent protein kinase is a rather nonspecific
enzyme that phosphorylates many exposed serine or threonine
residues which are 2-3 amino acid residues to the carboxyl
terminal side of two adjacent basic amino acids (21). Because
many such sequences become exposed during protein denatur-
ation (11), in vitro demonstration alone of phosphorylation by
cyclic AMP-dependent protein kinase may be of limited sig-
nificance . For example, histone H2b is extensively phosphor-
ylated in vitro by cyclic AMP-dependent protein kinases but
most cell types contain no detectable phosphorylated H2b in
vivo (11, 20, 34) . Also, the pattern of phosphorylation of
erythrocyte membrane that occurs in the intact cell is quite
different from that which occurs in vitro (41) . Present findings
in intact cells are not inconsistent with the in vitro results, but
designation ofvimentin as a substrate for cyclic AMP-depend-
ent protein kinase in vivo must await characterization of the
phosphorylation site. Phosphorylation by another protein ki-
nase that is activated indirectly by norepinephrine is in no way
excluded .
The glial origin of the C-6 cell line raises the consideration
of another fibrillary protein, the glial fibrillary acidic protein
(GFA), with respect to the identity of the 58K-5.7 protein.
Both GFA and vimentin form 10-nm filaments in glial cells
(30, 42), and the two proteins have similar solubility properties
' Browning, E. T .
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807(31). 58K-5.7 coincides in molecularweight with vimentin (54-
58,000) but is slightly larger than GFA (13). GFA is presentin
only a small fraction of C-6 cells especially in subconfluent
surface cultures (5, 23); however, antibody against 58K-5.7
reacted with filaments in essentially all of the cells of such
cultures (present work), suggesting that 58K-5.7 is different
from GFA. Finally, antibody againstvimentin reactedwith the
58K-5.7 protein of the 4 M urea extract of C-6 cell residues
(present work), These observations support the view that the
58K-5.7 protein is distinct from the GFA protein.
Hormone-dependent phosphorylation of vimentin in the
intact cell carries with it the implication of a functional role for
these structures in the mediation of norepinephrine effects on
C-6 cells. That the protein is phosphorylated on only a small
fraction of its copies may providean additional clue to therole
of phosphorylation of these structures. Clearly, the phosphor-
ylation relates to the role played by only a selected few copies,
at least at any one point in time. Further understanding of the
localization of the phosphorylated copies within the filament
might help in the understanding of the significance of phos-
phorylation of this cytoskeletal element.
Two classes of physiological effects of cyclic AMP elevation
within C-6 cells with which vimentin phosphorylation may be
associated are the induction of several enzymes (3, 14, 24, 36)
andachange in cellular shape toward one with more prominent
processes (28, 35). The induction of cyclic nucleotide phospho-
diesterase in C-6 cells is inhibited by vinblastine (38) which
disrupts microtubules and causes vimentin filaments to con-
dense into cables and perinuclear caps (30). Possibly, the
integrity of the vimentin filament and its phosphorylation are
required for the phosphodiesterase induction because protein
phosphorylation appears to be the major mechanism of cyclic
AMP action in mammalian cells (25). An involvement of
vimentin phosphorylation in cyclic AMP effects on cellular
shapemay also occur, possibly in concert with phosphorylative
controls of other cytoskeletal elements such as myosin light-
chain kinase phosphorylation by cyclic AMP-dependent pro-
tein kinase (1).
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